Third purchase in 31 days? Now that’s what I’m talking about. I’m starting to feel like the Lanny of old again, if only the grey hair can revert back to black, I’d appreciate it. January finished off with some tail winds, as big final year ...
In the U.S., one in eight women will be diagnosed with breast cancer in their lifetime; for men, the risk is one in 1,000. Game on: Jim Cramer is bullish on Electronic Arts, Activision Blizzard and Take-Two Interactive. Credit Suisse lowered …
U.S. drugmaker Pfizer (PFE) announced a new share repurchase program of up to $11 billion of its common stock Thursday night, deflating expectations that it will make a new bid for AstraZeneca. The New York-based …
Check out these four companies that are expected to release an earnings report during the week of July 31: Pfizer, Inc. (PFE) – Tuesday ... of 10.56% and revenue growth 5.55% this quarter. The stock also sports an Earnings ESP of …
Mycio Wealth Partners LLC reduced its position in shares of Pfizer, Inc. (NYSE:PFE) by 41.9% during the first quarter, according to its most recent filing with the SEC. Lord Abbett & Company bought 407,228 shares as the company's …
Considering that the stock daily volume of 13.38 million shares, this represents a pretty noteworthy trading in volume size that is above six million trading capacity in last session. Pfizer (NYSE:PFE) last posted its quarterly earnings data on …
Pfizer’s (NYSE:PFE) stock has been rising steadily on back of continued approvals nabbed by the drug maker in the last couple of months (Read Pfizer Secures Coveted FDA Approval For Eliquis and Pfizer Receives Big Boost As FDA …
With a market cap of 192182, Pfizer Inc. (NYSE:PFE) has a large market cap size. Pfizer Inc. (NYSE: PFE) has been on the stock market since its IPO date on the 6/1/1972. Pfizer Inc. is in the Drug Manufacturers – Major industry and …
But dig a little deeper, and the differences in the companies become more apparent, prompting some investing experts at the moment to favor JNJ stock over PFE. Johnson & Johnson is well-known for its consumer brands, while Pfizer is …